Liyan Lv
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- RNA Research and Splicing 2
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 3
- NF-κB Signaling Pathways 2
- Co-authors
- Xingwu Wang (5 shared papers)Nasha Zhang (3 shared papers)Ling Wei (3 shared papers)Ming Yang (3 shared papers)Ling Wei (8 shared papers)Xianrang Song (8 shared papers)Jujie Sun (4 shared papers)Yan Zheng (2 shared papers)
- Journals
- Oncotarget (3 papers)Molecular Cancer (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Cell Proliferation (1 paper)Cancer Biotherapy and Radiopharmaceuticals (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Liyan Lv
21 papers receiving 1.5k citations
Liyan Lv's Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 799
- Molecular Biology 863
- Oncology 211
- Immunology 123
- Pulmonary and Respiratory Medicine 149
Countries citing papers authored by Liyan Lv
This map shows the geographic impact of Liyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Lv more than expected).
Fields of papers citing papers by Liyan Lv
This network shows the impact of papers produced by Liyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Lv. The network helps show where Liyan Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyan Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Noncoding RNAs in gastric cancer: implications for drug resistance Hit paper breakdown → | 2020 | 363 |
| 2 | 2019 | 254 | |
| 3 | 2010 | 219 | |
| 4 | 2017 | 97 | |
| 5 | 2019 | 76 | |
| 6 | 2013 | 70 | |
| 7 | 2018 | 67 | |
| 8 | 2010 | 64 | |
| 9 | 2012 | 39 | |
| 10 | 2015 | 39 | |
| 11 | 2016 | 32 | |
| 12 | 2016 | 31 | |
| 13 | 2009 | 23 | |
| 14 | 2019 | 20 | |
| 15 | 2014 | 16 | |
| 16 | 2015 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2018 | 11 | |
| 19 | 2009 | 10 | |
| 20 | 2020 | 4 |
About Liyan Lv
Liyan Lv is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (2 papers), RNA Research and Splicing (2 papers), Epigenetics and DNA Methylation (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Cancer Research (799 citations), Molecular Biology (863 citations), Oncology (211 citations), Immunology (123 citations) and Pulmonary and Respiratory Medicine (149 citations). Liyan Lv has collaborated with scholars based in China and United States. Frequent co-authors include Xingwu Wang, Nasha Zhang, Ling Wei, Ming Yang, Ling Wei, Xianrang Song, Jujie Sun, Yan Zheng, Li Xie and Jiandong Liu. Their work appears in journals such as Oncotarget, Molecular Cancer, Journal of Experimental & Clinical Cancer Research, Cell Proliferation and Cancer Biotherapy and Radiopharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.